| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |